NL7905313A - PROCESS FOR PREPARING SALTS OF (-) - CIS-1,2-EPOXY-PROPYLPHOSPHONIC ACID. - Google Patents
PROCESS FOR PREPARING SALTS OF (-) - CIS-1,2-EPOXY-PROPYLPHOSPHONIC ACID. Download PDFInfo
- Publication number
- NL7905313A NL7905313A NL7905313A NL7905313A NL7905313A NL 7905313 A NL7905313 A NL 7905313A NL 7905313 A NL7905313 A NL 7905313A NL 7905313 A NL7905313 A NL 7905313A NL 7905313 A NL7905313 A NL 7905313A
- Authority
- NL
- Netherlands
- Prior art keywords
- acid
- cis
- epoxy
- salt
- solution
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000002253 acid Substances 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 10
- 239000004593 Epoxy Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 159000000000 sodium salts Chemical class 0.000 claims description 4
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims 1
- 206010073150 Multiple endocrine neoplasia Type 1 Diseases 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- -1 p-methyl mercaptophenyl Chemical group 0.000 claims 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- QWMFKVNJIYNWII-UHFFFAOYSA-N 5-bromo-2-(2,5-dimethylpyrrol-1-yl)pyridine Chemical compound CC1=CC=C(C)N1C1=CC=C(Br)C=N1 QWMFKVNJIYNWII-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical group CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- WUUPHKMXFXHDKJ-UHFFFAOYSA-L O.[Ca+2].P([O-])([O-])=O Chemical compound O.[Ca+2].P([O-])([O-])=O WUUPHKMXFXHDKJ-UHFFFAOYSA-L 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- QHFQAJHNDKBRBO-UHFFFAOYSA-L calcium chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2] QHFQAJHNDKBRBO-UHFFFAOYSA-L 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- REWRNTNUPNYYIE-UHFFFAOYSA-N sodium;tungsten;dihydrate Chemical compound O.O.[Na].[W] REWRNTNUPNYYIE-UHFFFAOYSA-N 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Description
- 1 - I -» Y.o. T959_____;___________________·_______ ___________- 1 - I - »Y.o. T959 _____; ___________________ · _______ ___________
Clesa S.p.A.Clesa S.p.A.
VicenzaVicenza
ItaliëItaly
Werkwijze om zouten te bereiden van (-)-cis-1,2-epoxypropylfosfonzuurProcess for preparing salts of (-) - cis-1,2-epoxypropylphosphonic acid
De uitvinding beeft betrekking op een· nieuwe werkwijze om . zouten te bereiden van (-)-cis-1,2-epoxypropylfosfonzuur, een antibioticum met breed spectrum. In bet bijzonder beeft de uitvinding betrekking op een werkwijze om zouten te bereiden van (-)-cis-1,2— • 5 epoxypropylf osfonzuur met: formule 1 van bet formuleblad en van een niet giftige base door uit te gaan van cis-1-propenylfosf onzuur met formule 2. en van L-(+)-threo-1 -(p-methylmercaptofenyl) -2-amino-1.3-propaandiol (verder aangeduid als tbiomicaoine) als splitsingsmiddel voor bet zuur met formule 1.The invention relates to a new method. to prepare salts of (-) - cis-1,2-epoxypropylphosphonic acid, a broad spectrum antibiotic. In particular, the invention relates to a process for preparing salts of (-) - cis-1,2 - epoxypropylphosphonic acid having: formula 1 of the formula sheet and of a non-toxic base starting from cis-1 -propenylphosphonic acid of formula 2. and of L - (+) - threo-1 - (p-methyl mercaptophenyl) -2-amino-1,3-propanediol (hereinafter referred to as tbiomicaoin) as an acid splitting agent of formula 1.
10 Het (-)-zuur met formule 1 en bun zouten met een niet giftige base worden op grote schaal gebruikt, zowel in de. menselijke als dierlijke geneeskunde· om. de groei van zowel Grampositieve en Gram— negatieve pathogene bacteriën te remmen.The (-) - acid of formula 1 and bun salts with a non-toxic base are widely used both in the. human and animal medicine · om. inhibit the growth of both Gram-positive and Gram-negative pathogenic bacteria.
De.· bereiding van bet racemische epoxyzuur met formule 1 is : 15 uit de literatuur bekend. Ook is bekend, bet racemische epoxyzuur te splitsen in hun optische actieve isomeren.The preparation of the racemic epoxy acid of formula 1 is known from the literature. It is also known to cleave the racemic epoxy acid into their optically active isomers.
Het volgens de literatuur meest gebruikte splitsingsmiddel is (+)-a-fenethylamine.The cleavage agent most commonly used in the literature is (+) - α-phenethylamine.
Verrassenderwijs is nu gevonden, dat men ook thicraicamine als 20 splitsingsmiddel kan gebruiken voor bet racemische epoxyzuur met formule 1, waardoor men rechtstreeks bet (-)-cis-1,2-epoxypropyl- « fosfonzuur verkrijgt.Surprisingly, it has now been found that thicraicamine can also be used as a cleaving agent for the racemic epoxy acid of the formula I, whereby directly (-) - cis-1,2-epoxypropyl-phosphonic acid is obtained.
Verder maakt de werkwijze volgens de uitvinding bet mogelijk, bet gebruikte thiamieamine vrijwel volledig terug te winnen (meer dan 93%).Furthermore, the process according to the invention makes it possible to recover almost all thiamieamine used (more than 93%).
25 Volgens de uitvinding wordt bet cis-1-propenylfosfonzuur met formule 2 geoxydeerd tot bet racemische epoxyzuur met formule 1 onder toepassing van waterstofperoxyde bij aanwezigheid van natriumwolfra-maatdihydraat. Nadat de overmaat waterstofperoxyde volledig is ontleed, wordt thiomicamine toegevoegd. De verkregen suspensie worde 30 alkalisch gemaakt met ÏJaQH, zodat een oplossing wordt verkregen van. het natriumzout van (-)-cis-1.2-epoxypropylfosfonzuur, dat dan 7905313 ' - 2 - * -S---^--;------- door een geschikte· "behandeling wordt omgezet in het zout van de ge— ·'’ · ’ wenste base.According to the invention, the cis-1-propenylphosphonic acid of the formula 2 is oxidized to the racemic epoxy acid of the formula 1 using hydrogen peroxide in the presence of sodium tungsten dihydrate. After the excess hydrogen peroxide has completely decomposed, thiomicamine is added. The resulting slurry is made alkaline with 11QH to give a solution of. the sodium salt of (-) - cis-1,2-epoxypropylphosphonic acid, which is then converted to the salt of the 7905313 - 2 - * -S --- ^ -; ------- by an appropriate treatment. desired base.
De oxydatie van het cis- 1-propenylfosfonzuur tot het overeenkomstige racemische epoxyzuur wordt op bekende wijze uitgevoerd 5 met waterstofperoxyde. als oxydatiemiddel en bij aanwezigheid van natriumwolframaatdihydraat. Nadat de oxydatie. is voltooid moet de overmaat waterstofperoxyde in het reactiemengsel volledig worden ontleed, voordat het thiomicamine wordt toegevoegd, daar dit anders zou. worden geoxydeerd.The oxidation of the cis-1-propenylphosphonic acid to the corresponding racemic epoxy acid is carried out in known manner with hydrogen peroxide. as an oxidizing agent and in the presence of sodium tungstate dihydrate. After the oxidation. is complete, the excess hydrogen peroxide in the reaction mixture must be completely decomposed before the thiomicamine is added, otherwise it would be. are oxidized.
.10 Na afloop, van de. oxydatie wordt het reactiemengsel behandeld met hydrazinehydraat; en een. katalytische hoeveelheid gereduceerd : koper bij 45-60°C. Het waterstofperoxyde ontleedt dan snel...10 Afterwards, of the. oxidation, the reaction mixture is treated with hydrazine hydrate; and a. catalytic amount reduced: copper at 45-60 ° C. The hydrogen peroxide then decomposes quickly.
De toevoeging van thiomicamine aan het reactiemengsel, dat het racemische. epoxyzuur met formule 1 bevat,, wordt geleidelijk uitge-15 voerd,. terwijl de pH op 5-6 wordt gehouden door toevoegen van zuur.The addition of thiomicamine to the reaction mixture, which is racemic. epoxy acid of formula I, is carried out gradually. while maintaining the pH at 5-6 by adding acid.
De uitvinding wordt toegelicht door· de volgende voorbeelden Voorbeeld ΓThe invention is illustrated by the following examples Example Γ
Bereiding van het calciumzout van (-)-cis—1,2-epaxypropylfosfonzuur-monohydraat..Preparation of the calcium salt of (-) - cis-1,2-epaxypropylphosphonic acid monohydrate.
20 In 3500 ml, water wordt 600 g· (1+,91 mol) cis-1-propenylfosfon— zuur opgelost en de pH wordt ingesteld op 5,9 met 30# natriumhydroxyde-oplossing. Een oplossing van. 11,2 g natriumwolframaatdihydraat, U,8 g dinatriumedetaat en 53 ml water wordt aan de zo verkregen oplossing toegevoegd onder roeren bij kamertemperatuur.600 g (1 +, 91 mol) of cis-1-propenylphosphonic acid are dissolved in 3500 ml of water and the pH is adjusted to 5.9 with 30% sodium hydroxide solution. A solution of. 11.2 g of sodium tungstate dihydrate, U, 8 g of disodium edetate and 53 ml of water are added to the solution thus obtained with stirring at room temperature.
25 De zo verkregen oplossing wordt verwarmd op l+5-50°C en dan wordt 620 g (7,3 mol) l+0#rs waterstofperoxyde-oplossing langzaam en onder roeren toegevoegd. Nadat alles is toegevoegd, laat men bij deze temperatuur de oplossing anderhalf uur staan.'The solution thus obtained is heated to 1 + 5-50 ° C and then 620 g (7.3 mol) 1 + 0 # rs hydrogen peroxide solution is added slowly and with stirring. After everything has been added, the solution is left for an hour and a half at this temperature. '
Daarna voegt men 3,2 g (0,06U mol) hydrazinehydraat en 0,32 g 30 gereduceerd koper bij de oplossing.Then 3.2 g (0.06 U mol) of hydrazine hydrate and 0.32 g of reduced copper are added to the solution.
De van oxydatiemiddel bevrijde oplossing wordt afgekoeld tot 20°C, ontkleurd, gefiltreerd en behandeld met ‘ 10h-5 g (h-,91 mol) L-(+)-threo-1 -(p-methylmercaptofenyl)-2-amino—1,3-propaandiol (thiomicamine) bij kamertemperatuur en onder roeren, terwijl gelijktijdig geconcen-35 treerd HC1 wordt toegevoegd om de pH tussen 5 en 6 te houden.The solution liberated from oxidizing agent is cooled to 20 ° C, decolorized, filtered and treated with 10h-5 g (h-, 91 mol) L - (+) - threo-1 - (p-methyl mercaptophenyl) -2-amino— 1,3-propanediol (thiomicamine) at room temperature and with stirring, while concentrated HCl is added simultaneously to maintain the pH between 5 and 6.
Het thiomicamine wordt geleidelijk toegevoegd en telkens wordt 7905313 w -3- een geringe hoeveelheid zoutzuur toegevoegd can de pH van het mengsel tussen. 5 en 6 te houden. Nadat alles is toegevoegd is de pH 598.The thiomicamine is added gradually and each time a small amount of hydrochloric acid is added to the pH of the mixture. 5 and 6. After everything is added, the pH is 598.
Men laat het geheel onder roeren 1 uur staan hij kamertemperatuur, koelt het daarna af tot 0°C ai na 2 uur wordt het gevormde 5 neerslag af gefiltreerd en gewassen met water. Uit de moederloog wordt 265 g thiomicamine teruggewonnen door de oplossing alkalisch te maken- Het verkregen neerslag, dat bestaat uit het thicmicaminezout van (-)-cis-1,2-epozypropylfosfonzuur wordt gekristalliseerd uit isopropanol· en gesuspendeerd in 2700 ml water. Het mengsel wordt hij 10 kamertemperatuur geroerd en met 10* NaOH-oplossing alkalisch gemaakt.The whole is allowed to stand under stirring for 1 hour at room temperature, then it is cooled to 0 ° C. After 2 hours, the precipitate formed is filtered off and washed with water. 265 g of thiomicamine are recovered from the mother liquor by making the solution alkaline. The precipitate obtained, which consists of the thicmicamine salt of (-) - cis-1,2-epozypropylphosphonic acid, is crystallized from isopropanol and suspended in 2700 ml of water. The mixture is stirred at room temperature and made alkaline with 10% NaOH solution.
Na 1 uur. roeren wordt het nog aanwezige thiomicamine afgefiltreerd. Het gedroogde thiomicamine weegt 570 g.1 hour later. the thiomicamine still present is filtered off with stirring. The dried thiomicamine weighs 570 g.
Uit de waterige oplossing, welke het natriumzout hevat van (-)-cis-1,2-epoxypropylfosf onzuur wordt het overeenkomstige calcium-V? zout in de. vorm van. het monohydraat neergeslagen door toevoegen van 760 g (3,^7 mol) oplossing van calciumchloridehexahydraat in J60 ml water- Het gevormde calciumzout wordt afgefiltreerd, gewassen met water en gedroogd. Opbrengst 250 g.The corresponding calcium V is obtained from the aqueous solution which contains the sodium salt of (-) - cis-1,2-epoxypropylphosphonic acid. salt in the. shape of. the monohydrate precipitated by adding 760 g (3, 7 mol) solution of calcium chloride hexahydrate in J60 ml of water. The calcium salt formed is filtered off, washed with water and dried. Yield 250 g.
[α]^° * -6° (0,3* H20); [a]^5 » -18° (0,3* HgO).[α] ° °--6 ° (0.3 * H 2 O); [α] 25D -18 ° (0.3 * HgO).
20 Door afdestilleren van het isopropanol, dat nog in de moeder logen aanwezig is, gevolgd door alkalisch maken van het residu, verkrijgt men nog 1^1 g thiomicamine.Distillation of the isopropanol, which is still present in the mother liquors, followed by alkalizing the residue, yields 1 µl of thiomicamine.
Voorbeeld IIExample II
Bereiding van het calciumzout van (+}-cis-1,2-epozypropylfosfonzuur-2 5 monohydraat.Preparation of the calcium salt of (+} - cis-1,2-epozypropylphosphonic acid-2 monohydrate.
Men gaat te werk zoals in voorbeeld I, maar vervangt het L-(-)-threo-1-(p-methylmercaptofenyl)-2-amino-1,3-propaandiol door de overeenkomstige L-(+)-verbinding en verkrijgt dan 2^5 g (+)-cis-1,2-epoxypropylcalciumfos fonaatmonohydr aat.Proceed as in Example 1, but replace the L - (-) - threo-1- (p-methylmercaptophenyl) -2-amino-1,3-propanediol with the corresponding L - (+) compound and then obtain 2 ^ 5 g (+) - cis-1,2-epoxypropyl calcium phosphonate monohydrate.
30 [a]^° = +6° (0,3* HgO); [a]^ = +18° (0,3* HgO)30 [α] D 25 = + 6 ° (0.3 * HgO); [a] ^ = + 18 ° (0.3 * HgO)
Voorbeeld IIIExample III
Bereiding van het dinatriumzout van (-)-cis-l ,2-epozypropylfosfonzuur.Preparation of the disodium salt of (-) - cis-1,2-epozypropylphosphonic acid.
Men gaat te werk zoals in voorbeeld I, totdat de waterige oplossing is verkregen, welke het natriumzout van (-)-cis-1,2-epoxy-35 propyifosfonzuur bevat.Proceed as in Example 1 until the aqueous solution containing the sodium salt of (-) - cis-1,2-epoxy-propyiphosphonic acid is obtained.
De pH van deze oplossing wordt met azijnzuur ingesteld op 8,8.The pH of this solution is adjusted to 8.8 with acetic acid.
790 53 13790 53 13
„ V"V
* - , - . · - k - . - '* -, -. - - k -. - '
Daarna wordt het geheel in vacuum drooggedamptwaarbij:\men een • ' stroop verkrijgt, waaruit door behandeling met ethanol, het dinatrium- zout van (~)-cis-1,2-epoxypropylfosfonzuur kristalliseert.The whole is then evaporated to dryness in vacuo, whereby a syrup is obtained, from which the disodium salt of (-) - cis-1,2-epoxypropylphosphonic acid crystallizes by treatment with ethanol.
Opbrengst 285 g» 5 [a]^° = -5° (5% ïï20); [a]|g5. = -17° (5% HgÖ).Yield 285 g of 5 [α] 25 ° -5 ° (5% 20); [a] | g5. = -17 ° (5% HgO).
7. * \ i 790 53 137. * \ i 790 53 13
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT25389/78A IT1097477B (en) | 1978-07-06 | 1978-07-06 | METHOD FOR THE PREPARATION OF SALTS OF (-) CIS-1,2-EPOXYPROPYLPHOSPHONIC ACID |
IT2538978 | 1978-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7905313A true NL7905313A (en) | 1980-01-08 |
Family
ID=11216556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7905313A NL7905313A (en) | 1978-07-06 | 1979-07-06 | PROCESS FOR PREPARING SALTS OF (-) - CIS-1,2-EPOXY-PROPYLPHOSPHONIC ACID. |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5511575A (en) |
AT (1) | AT373264B (en) |
CA (1) | CA1131648A (en) |
CH (1) | CH640863A5 (en) |
DE (1) | DE2925359C3 (en) |
DK (1) | DK284679A (en) |
ES (1) | ES482227A1 (en) |
FR (1) | FR2430424A1 (en) |
GB (1) | GB2024826B (en) |
GR (1) | GR69597B (en) |
IE (1) | IE48590B1 (en) |
IT (1) | IT1097477B (en) |
NL (1) | NL7905313A (en) |
SE (1) | SE446739B (en) |
-
1978
- 1978-07-06 IT IT25389/78A patent/IT1097477B/en active
-
1979
- 1979-06-09 JP JP7185879A patent/JPS5511575A/en active Pending
- 1979-06-12 CH CH549079A patent/CH640863A5/en not_active IP Right Cessation
- 1979-06-22 DE DE2925359A patent/DE2925359C3/en not_active Expired
- 1979-06-22 FR FR7916110A patent/FR2430424A1/en active Granted
- 1979-06-27 GB GB7922413A patent/GB2024826B/en not_active Expired
- 1979-06-28 AT AT0455279A patent/AT373264B/en not_active IP Right Cessation
- 1979-07-03 GR GR59500A patent/GR69597B/el unknown
- 1979-07-05 SE SE7905874A patent/SE446739B/en not_active IP Right Cessation
- 1979-07-05 DK DK284679A patent/DK284679A/en not_active Application Discontinuation
- 1979-07-05 ES ES482227A patent/ES482227A1/en not_active Expired
- 1979-07-06 NL NL7905313A patent/NL7905313A/en not_active Application Discontinuation
- 1979-07-06 CA CA331,340A patent/CA1131648A/en not_active Expired
- 1979-08-08 IE IE1272/79A patent/IE48590B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE48590B1 (en) | 1985-03-20 |
DE2925359B2 (en) | 1980-09-04 |
FR2430424A1 (en) | 1980-02-01 |
ES482227A1 (en) | 1980-04-01 |
SE7905874L (en) | 1980-01-07 |
GB2024826B (en) | 1982-12-01 |
IT7825389A0 (en) | 1978-07-06 |
JPS5511575A (en) | 1980-01-26 |
IT1097477B (en) | 1985-08-31 |
GR69597B (en) | 1982-07-05 |
ATA455279A (en) | 1983-05-15 |
IE791272L (en) | 1980-01-06 |
SE446739B (en) | 1986-10-06 |
GB2024826A (en) | 1980-01-16 |
FR2430424B1 (en) | 1985-04-12 |
DK284679A (en) | 1980-01-07 |
CH640863A5 (en) | 1984-01-31 |
DE2925359C3 (en) | 1981-08-06 |
DE2925359A1 (en) | 1980-01-24 |
AT373264B (en) | 1984-01-10 |
CA1131648A (en) | 1982-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL192266C (en) | Process for preparing a crystalline cefepime dihydrochloride as well as the crystalline dihydrochloride and mixtures containing it. | |
JPH0313237B2 (en) | ||
RU2550202C2 (en) | Method of synthesising ergothioneine and its analogues | |
CZ277907B6 (en) | Cefodizime disodium salt preparation process | |
CS207646B2 (en) | Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid | |
JPH045038B2 (en) | ||
SU845789A3 (en) | Method of preparing d-7-/alpha-(4-oxy-6-methylnicotineamido)-alpha-(4-oxyphenyl)-acetamido/-3-(1-methyltetrazol-5-yl) thiomethyl-3-cephem-4-carboxylic acid | |
EP1618114B1 (en) | Processes for the preparations of cefepime | |
NL7905313A (en) | PROCESS FOR PREPARING SALTS OF (-) - CIS-1,2-EPOXY-PROPYLPHOSPHONIC ACID. | |
US3853863A (en) | Cephalosporin c isolation process | |
NO174258B (en) | Analogous Process for Preparation of Therapeutically Active Crystalline Cephemic Acid Salts | |
US3862186A (en) | Process for the production of cephalexin monohydrate | |
JPH0128744B2 (en) | ||
CS195746B2 (en) | Process for preparing crystalline methanolate of natrium salt of cephamandole | |
KR830000567B1 (en) | Process for preparing salts of (-) cis-1,2-epoxypropylphosphonic acid | |
EP0035811B1 (en) | Process for resolving dl-s-benzoyl-beta-mercaptoisobutyric acid, and products obtained by applying this process | |
KR0135979B1 (en) | Method for recovery of anti-biotics from mother liquors | |
EP0094639B1 (en) | Sodium 7-beta-(2d-2-amino-2-carboxyethylthioacetamido)-7-alpha-methoxy-3-(1-methyl-1h-tetrazol-5-yl)-thiomethyl-3-cephem-4-carboxylate heptahydrate, process for its preparation as well as pharmaceutical compositions containing same | |
SU730303A3 (en) | Method of preparing thiazolidine carboxylic acids or their acid-additive salts | |
US4180660A (en) | Cephalosporin derivatives | |
US5175264A (en) | 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid | |
JPH0128743B2 (en) | ||
US5264573A (en) | Process for preparing 2-chloro-1,7-dihydropurin-6-one and a process for its purification | |
US4122260A (en) | Cephalosporin derivatives | |
JPS5852253A (en) | P-hydroxyphenylglycine-alpha-phenylethanesulfonic acid salt and its optical resolution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1A | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |